MedTrace Logo

Safety and Dose Escalation Study of Zinc Supplementation in Critically Ill Children

NCT01062009 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2019-08-20

Study results available
· View outcomes & findings →

Summary

The purpose of the study is 1) to determine whether administration of intravenous zinc to critically ill children is safe, and 2) to determine an appropriate dose of zinc supplementation.

Conditions

  • Critical Illness

Interventions

DRUG

Zinc sulfate

Zinc sulfate 200 mcg/ml in Normal Saline

Sponsors & Collaborators

  • Children's Hospital Medical Center, Cincinnati

    collaborator OTHER

  • UCSF Benioff Children's Hospital Oakland

    lead OTHER

Principal Investigators

  • Natalie Z Cvijanovich, MD · UCSF Benioff Children's Hospital Oakland

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Days
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2014-10-31
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01062009 on ClinicalTrials.gov